GAIN THERAPEUTICS, INC Income (Loss) from Continuing Operations before Income Taxes, Domestic
GAIN THERAPEUTICS, INC (GANX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$22.48 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-26
- GAIN THERAPEUTICS, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$22.48M.
- GAIN THERAPEUTICS, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$22.39M.
- GAIN THERAPEUTICS, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$22.48M.
- GAIN THERAPEUTICS, INC income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$17.34M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$22.48M 10-K · filed 2026-03-26 |
| 2024-12-31 | -$22.39M 10-K · filed 2026-03-26 |
| 2023-12-31 | -$22.48M 10-K · filed 2025-03-27 |
| 2022-12-31 | -$17.34M 10-K · filed 2024-03-26 |
| 2021-12-31 | -$7.60M 10-K · filed 2023-03-23 |
| 2020-12-31 | -$623.67K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |